Microbial metabolism of host-derived antioxidants DOI
Zhe Zhou, Stavroula K. Hatzios

Current Opinion in Chemical Biology, Год журнала: 2024, Номер 84, С. 102565 - 102565

Опубликована: Дек. 24, 2024

Язык: Английский

Dietary index for gut microbiota is associated with stroke among US adults DOI
Jingjing Liu, Shaoqiang Huang

Food & Function, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

The dietary index for gut microbiota was inversely associated with stroke prevalence, particularly in adults aged 30 years and above.

Язык: Английский

Процитировано

9

Clinical translation of microbiome research DOI
Jack A. Gilbert, Meghan B. Azad, Fredrik Bäckhed

и другие.

Nature Medicine, Год журнала: 2025, Номер unknown

Опубликована: Апрель 11, 2025

Язык: Английский

Процитировано

3

Bidirectional Interplay Among Non-Coding RNAs, the Microbiome, and the Host During Development and Diseases DOI Open Access

Shanshan Nai,

Ji‐Ying Song, Wenting Su

и другие.

Genes, Год журнала: 2025, Номер 16(2), С. 208 - 208

Опубликована: Фев. 8, 2025

It is widely known that the dysregulation of non-coding RNAs (ncRNAs) and dysbiosis gut microbiome play significant roles in host development progression various diseases. Emerging evidence has highlighted bidirectional interplay between ncRNAs microbiome. This article aims to review current understanding molecular mechanisms underlying crosstalk ncRNAs, especially microRNA (miRNA), context diseases, such as colorectal cancer, inflammatory bowel neurological disorders, obesity, cardiovascular disease. Ultimately, this seeks provide a foundation for exploring potential interactions biomarkers therapeutic targets clinical diagnosis treatment, ncRNA mimics, antisense oligonucleotides, small-molecule compounds, well probiotics, prebiotics, diets.

Язык: Английский

Процитировано

1

Harnessing gut microbial communities to unravel microbiome functions DOI Creative Commons

Samir Giri,

Handuo Shi, Athanasios Typas

и другие.

Current Opinion in Microbiology, Год журнала: 2025, Номер 83, С. 102578 - 102578

Опубликована: Янв. 8, 2025

Язык: Английский

Процитировано

1

Chemical activity profiling reveals how exposure to drugs or dietary compounds alters gut microbial biotransformation capacity DOI Creative Commons
Hélène Bigonne, Shuhuan Zhai, Jacob Folz

и другие.

bioRxiv (Cold Spring Harbor Laboratory), Год журнала: 2025, Номер unknown

Опубликована: Май 20, 2025

Abstract The gut microbiome catalyzes biotransformation reactions that influence intestinal absorption as a basis of microbiome-host interactions. A better understanding microbiota capacity, and its alteration in dysregulated states, would enable the prediction individual responses to drugs toxins improve safety assessment. Here, we profiled chemical activities rat ex vivo, quantified capacity changes induced by oral exposure eight dietary compounds: tobramycin, colistin, acesulfame potassium, saccharin, bovine serum albumin (BSA), meropenem, doripenem, daidzein. We implemented an approach involving inoculation with metabolic probes during fermentations measured their degradation. In most groups, observed no however, detected significant alterations rates after doripenem tobramycin. Interestingly, common patterns were microbiomes from rats exposed carbapenems partially shared These results aligned well prior metagenomic metabolomic findings. Further, correlations between microbial taxa reaction assessed establish link specific bacteria probe This functionally relevant strategy revealed vivo exposures.

Язык: Английский

Процитировано

0

Global metabolite profiling in feces, serum, and urine yields insights into energy balance phenotypes induced by diet-driven microbiome remodeling DOI Open Access
Daria Igudesman, Gongxin Yu, Tumpa Dutta

и другие.

medRxiv (Cold Spring Harbor Laboratory), Год журнала: 2025, Номер unknown

Опубликована: Фев. 6, 2025

Abstract Background. Preclinical literature and behavioral human data suggest that diet profoundly impacts the gut microbiome energy absorption—a key determinant of balance. To determine whether these associations are causal, domiciled controlled feeding studies with precise measurements dietary intake balance needed. Metabolomics—a functional readout modulation—can help identify putative mechanisms mediating effects. We previously demonstrated a high-fiber, minimally processed Microbiome Enhancer Diet (MBD) fed at decreased absorption increased microbial biomass relative to calorie-matched fiber-poor, highly Western (WD). Objective. metabolic signatures distinguishing MBD from WD potential metabolomic MBD-induced negative Methods. deployed global metabolomics in feces, serum, urine using samples collected end randomized crossover trial delivering 22 days an 17 persons without obesity. Samples were while participants on ward analyzed Ultrahigh Performance Liquid Chromatography-Tandem Mass Spectroscopy. Linear mixed effects models tested metabolite changes by diet. Weighted gene network correlation analysis identified modules correlated phenotypes. Results. Numerous metabolites consistently altered fasting and/or may serve as biomarkers feeding. Fecal diet-microbiota co-metabolites reduced biomass. An shifted urinary metabolome sugar degradation ketogenesis—evidence Conclusions. Precisely diets disparate microbiota-accessible substrates led distinct urine. These be “fed” or “starved” (WD) microbiota associated findings lay foundation for unveiling causal pathways linking co-metabolism absorption.

Язык: Английский

Процитировано

0

Does Gut Microbiome Composition Influence the Efficacy of Psychiatric Drugs? DOI Creative Commons

Nadia Suryawinata,

Sarkis K. Mazmanian

European Medical Journal, Год журнала: 2025, Номер unknown

Опубликована: Март 13, 2025

Altered gut microbiome profiles correlate with anxiety and depression in humans, work animal models has identified specific bacterial taxa and/or microbiome-derived metabolites that influence complex emotional behaviours. Intriguingly, many pharmaceuticals, including widely used oral treatments for depression, can be chemically modified by microbes the gastrointestinal tract, which may lead to drug inactivation. The authors highlight importance of integrating research across microbial culture systems, models, multi-omics analyses clinical cohorts gain mechanistic insights into whether composition determines efficacy, bioavailability, tolerability neuropsychiatric medications. This hypothesis, if validated, have profound implications personalised treatment plans microbiome-based biomarker development.

Язык: Английский

Процитировано

0

Discovery of an ene-reductase initiating resveratrol catabolism in gut microbiota and its application in disease treatment DOI Creative Commons

Zhixiang Dong,

Peijun Yu,

Jianxu Li

и другие.

Cell Reports, Год журнала: 2025, Номер 44(4), С. 115517 - 115517

Опубликована: Апрель 1, 2025

Resveratrol (RSV) is a plant-derived natural compound with multiple biological activities. Upon entering the intestine, RSV undergoes rapid metabolism and transformation by gut microbiota. In this study, we isolated bacterium capable of efficiently metabolizing RSV, Eggerthella lenta J01. Through induced enrichment transcriptomics bioinformatic analyses, identified an reductase (RER) from E. Using RER structure simulation, site-directed mutagenesis, biochemical assays, further determined key amino acids in associated catalytic activity. Studies animal models demonstrated that enhances RSV's ability to alleviate inflammatory bowel disease. Additionally, bioinformatics analysis revealed abundance rer gene microbiota healthy individuals was higher than patients enteritis. Collectively, these findings suggest activity products may be modulated through metabolic transformations.

Язык: Английский

Процитировано

0

Association between dietary index for gut microbiota and chronic kidney disease: A cross-sectional study from U.S. population DOI Creative Commons
Xiaodong Zhou, Changchuan Jiang,

Byeng-Chun Song

и другие.

Preventive Medicine Reports, Год журнала: 2025, Номер unknown, С. 103060 - 103060

Опубликована: Апрель 1, 2025

Objective: Emerging evidence suggests that diet modulates gut microbiota, which in turn influences chronic kidney disease (CKD) progression. This study investigates the association between newly proposed Dietary Index for Gut Microbiota (DI-GM) and prevalence prognosis of CKD. Methods: cross-sectional analyzed data from U.S. National Health Nutrition Examination Survey 2007-2020. DI-GM scores were calculated based on dietary intake 14 food components, categorized as beneficial or unfavorable. Weighted linear regression model, logistic restricted cubic spline analysis used to assess associations with Results: The CKD among 28,512 participants was 17.4 %. Higher negatively associated (OR = 0.967, 95 %CI: 0.939-0.995, p 0.026) very high-risk 0.877, 0.821-0.937, < 0.001). Beneficial components significantly lower risk 0.928, 0.892-0.966, 0.001), while no significant observed unfavorable components. levels linearly improved (p trend <0.001). Coffee fiber primary contributors both CKD, whole grains primarily impacted its prognosis. Conclusions: DI-GM, driven by is reduced These findings suggest promoting patterns enhance microbiota may play a pivotal role management.

Язык: Английский

Процитировано

0

Moving from genome-scale to community-scale metabolic models for the human gut microbiome DOI

Nick Quinn-Bohmann,

Alex V. Carr,

Christian Diener

и другие.

Nature Microbiology, Год журнала: 2025, Номер unknown

Опубликована: Апрель 11, 2025

Язык: Английский

Процитировано

0